Pediatric sepsis and multiple organ dysfunction syndrome

被引:45
作者
Despond, O
Proulx, F
Carcillo, JA
Lacroix, J
机构
[1] Univ Montreal, Hop St Justine, Dept Pediat, Div Pediat Intens Care, Montreal, PQ H3T 1C5, Canada
[2] Childrens Hosp Pittsburgh, Pittsburgh, PA 15213 USA
[3] Dept Anesthesiol, Div Crit Care Med, Pittsburgh, PA USA
关键词
D O I
10.1097/00008480-200106000-00006
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Systemic inflammatory response syndrome may be viewed as the systemic expression of cytokine signals that normally function on an autocrine or paracrine level. Sepsis is defined as systemic inflammatory response syndrome caused by an infection. Multiple organ dysfunction syndrome may represent the end stage of severe systemic inflammatory response syndrome or sepsis. Many cells are involved, including endothelial cells and leukocytes and multiple proinflammatory and antiinflammatory mediators (cytokines, oxygen free radicals, coagulation factors; and so forth), Various pathophysiologic mechanisms have been postulated. The most popular theorys that the inflammatory process loses its autoregulatory capacity; however, microcirculatory dysregulation and apoptosis may also be important, and a new paradigm posits a complex nonlinear system. Many new treatments have been studied recently. The usefulness of immune modulating diets remains to be evaluated, Molecular immunomodulation is still of unclear value. The therapy of sepsis:and multiple organ dysfunction syndrome remains mainly supportive. Curr Opin Pediatr 2001 13:247-253 (C) 2001 Lippincott Williams & Wilkins, Inc.
引用
收藏
页码:247 / 253
页数:7
相关论文
共 68 条
  • [31] Impact of colony-stimulating factor therapy on clinical outcome and frequency rate of nosocomial infections in intensive care unit neutropenic patients
    Gruson, D
    Hilbert, G
    Vargas, F
    Valentino, R
    Chene, G
    Boiron, JM
    Reiffers, J
    Gbikpi-Benissan, G
    Cardinaud, JP
    [J]. CRITICAL CARE MEDICINE, 2000, 28 (09) : 3155 - 3160
  • [32] Procalcitonin and cytokine levels: Relationship to organ failure and mortality in pediatric septic shock
    Hatherill, M
    Tibby, SM
    Turner, C
    Ratnavel, N
    Murdoch, IA
    [J]. CRITICAL CARE MEDICINE, 2000, 28 (07) : 2591 - 2594
  • [33] Hatherill M, 1999, ARCH DIS CHILD, V81, P417, DOI 10.1136/adc.81.5.417
  • [34] A multicenter, randomized, controlled clinical trial of transfusion requirements in critical care
    Hébert, PC
    Wells, G
    Blajchman, MA
    Marshall, J
    Martin, C
    Pagliarello, G
    Tweeddale, M
    Schweitzer, I
    Yetisir, E
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1999, 340 (06) : 409 - 417
  • [35] Plasmafiltration in sepsis: Removing the evil humors
    Holmes, CL
    Russell, JA
    [J]. CRITICAL CARE MEDICINE, 1999, 27 (10) : 2287 - 2289
  • [36] Apoptotic cell death in patients with sepsis, shock, and multiple organ dysfunction
    Hotchkiss, RS
    Swanson, PE
    Freeman, BD
    Tinsley, KW
    Cobb, JP
    Matuschak, GM
    Buchman, TG
    Karl, IE
    [J]. CRITICAL CARE MEDICINE, 1999, 27 (07) : 1230 - 1251
  • [37] Myopathy in critically ill patients
    Hund, E
    [J]. CRITICAL CARE MEDICINE, 1999, 27 (11) : 2544 - 2547
  • [38] Microcirculatory oxygenation and shunting in sepsis and shock
    Ince, C
    Sinaasappel, M
    [J]. CRITICAL CARE MEDICINE, 1999, 27 (07) : 1369 - 1377
  • [39] LECLERC F, 2000, 3 WORLD C PED INT CA
  • [40] Development of a pediatric multiple organ dysfunction score: Use of two strategies
    Leteurtre, S
    Martinot, A
    Duhamel, A
    Gauvin, F
    Grandbastien, B
    Nam, TV
    Proulx, F
    Lacroix, J
    Leclerc, F
    [J]. MEDICAL DECISION MAKING, 1999, 19 (04) : 399 - 410